Venetoclax plus bortezomib and dexamethasone in heavily pretreated end‐stage myeloma patients without t(11;14): A real‐world cohort. Issue 3 (23rd April 2020) - Jelinek, Tomas; Popkova, Tereza; Duras, Juraj; Mihalyova, Jana; Kascak, Michal; Benkova, Katerina; Plonkova, Hana; Cerna, Lucie; Koristek, Zdenek; Simicek, Michal; Hajek, Roman